Sumoylation: Implications for Neurodegenerative Diseases

被引:46
|
作者
Anderson, Dina B. [1 ]
Zanella, Camila A. [2 ]
Henley, Jeremy M. [3 ]
Cimarosti, Helena [2 ]
机构
[1] Ipsen Bioinnovat Ltd, Units Quadrant 4 10, Barton Lane, Abingdon OX14 3YS, Oxon, England
[2] Univ Fed Santa Catarina, Dept Pharmacol, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Bristol, Sch Biochem, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会; 英国惠康基金;
关键词
Alzheimer's disease; Amyotrophic lateral sclerosis; Ischemia; Neuronal intranuclear inclusion disease; Parkinson's disease; Polyglutamine diseases; Drug targets; INTRANUCLEAR INCLUSION DISEASE; ALPHA-SYNUCLEIN AGGREGATION; FAMILIAL PARKINSONS-DISEASE; MODIFIER SUMO MODIFICATION; A-BETA GENERATION; PROTEIN SUMOYLATION; ENHANCED SUMOYLATION; ALZHEIMERS-DISEASE; ANDROGEN RECEPTOR; MOUSE MODEL;
D O I
10.1007/978-3-319-50044-7_16
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The covalent posttranslational modifications of proteins are critical events in signaling cascades that enable cells to efficiently, rapidly and reversibly respond to extracellular stimuli. This is especially important in the CNS where the processes affecting synaptic communication between neurons are highly complex and very tightly regulated. Sumoylation regulates the function and fate of a diverse array of proteins and participates in the complex cell signaling pathways required for cell survival. One of the most complex signaling pathways is synaptic transmission. Correct synaptic function is critical to the working of the brain and its alteration through synaptic plasticity mediates learning, mental disorders and stroke. The investigation of neuronal sumoylation is a new and exciting field and the functional and pathophysiological implications are far-reaching. Sumoylation has already been implicated in a diverse array of neurological disorders. Here we provide an overview of current literature highlighting recent insights into the role of sumoylation in neurodegeneration. In addition we present a brief assessment of drug discovery in the analogous ubiquitin system and extrapolate on the potential fordevelopment of novel therapies that might target SUMO-associated mechanisms of neurodegenerative disease.
引用
收藏
页码:261 / 281
页数:21
相关论文
共 50 条
  • [21] Regulation of neuronal autophagy and the implications in neurodegenerative diseases
    Cai, Qian
    Ganesan, Dhasarathan
    NEUROBIOLOGY OF DISEASE, 2022, 162
  • [22] Neuronal biomolecular condensates and their implications in neurodegenerative diseases
    Nam, Jeongyeon
    Gwon, Youngdae
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [23] Autophagy regulation by acetylation—implications for neurodegenerative diseases
    Sung Min Son
    So Jung Park
    Marian Fernandez-Estevez
    David C. Rubinsztein
    Experimental & Molecular Medicine, 2021, 53 : 30 - 41
  • [24] Therapeutic implications of circadian clocks in neurodegenerative diseases
    Chang, Yu Chen
    Kim, Jin Young
    JOURNAL OF NEUROSCIENCE RESEARCH, 2020, 98 (06) : 1095 - 1113
  • [25] Protein misfolding in neurodegenerative diseases: implications and strategies
    Sweeney, Patrick
    Park, Hyunsun
    Baumann, Marc
    Dunlop, John
    Frydman, Judith
    Kopito, Ron
    McCampbell, Alexander
    Leblanc, Gabrielle
    Venkateswaran, Anjli
    Nurmi, Antti
    Hodgson, Robert
    TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [26] Stress responses in oligodendrocytes: implications for neurodegenerative diseases
    Richter-Landsberg, C.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 : 5 - 5
  • [27] AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
    Marinangeli, Claudia
    Didier, Sebastien
    Vingtdeux, Valerie
    CURRENT DRUG TARGETS, 2016, 17 (08) : 890 - 907
  • [28] Ryanodine Receptors in Autophagy: Implications for Neurodegenerative Diseases?
    Vervliet, Tim
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [29] TSPO AND CELL DEATH IMPLICATIONS FOR CANCER AND NEURODEGENERATIVE DISEASES
    Gavish, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 10 - 10
  • [30] Implications of mtDNA somatic mutation on aging and neurodegenerative diseases
    Marciniak, Christine
    Coskun, Pinar
    Wallace, Douglas C.
    MITOCHONDRION, 2010, 10 (02) : 236 - 236